𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SCRN1 is a novel marker for prognosis in colorectal cancer

✍ Scribed by Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
90 KB
Volume
101
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


SCRN1 is a novel marker for prognosis in
✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## Purpose Secernin 1 (__SCRN1__) is a member of the secernin family and is reported to be a tumor‐associated antigen. Previous reports show that __SCRN1__ is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer

SMAD7 is a prognostic marker in patients
✍ Jean-Louis Boulay; Gabriele Mild; Adam Lowy; Juergen Reuter; Magali Lagrange; Lu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 82 KB

## Abstract Chromosomal region 18q21 is frequently deleted in colorectal cancer (CRC) and is associated with poor prognosis. Potential tumor suppressor mechanisms altered by 18q21 deletion include mediation of TGFΞ² signaling by SMADs. Following the definition of __SMAD4__ deletion as a negative pre

MUC12 mRNA expression is an independent
✍ Takatoshi Matsuyama; Toshiaki Ishikawa; Kaoru Mogushi; Tsuyoshi Yoshida; Satoru πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 365 KB πŸ‘ 1 views

## Abstract Distant metastasis is the major cause of death in colorectal cancer (CRC) patients. To identify genes influencing the prognosis of patients with CRC, we compared gene expression in primary tumors with and without distant metastasis using an oligonucleotide microarray. We also examined t